Literature DB >> 20100956

Developing immunotherapy as legitimate therapy for patients with prostate cancer.

Eric J Small, Lawrence Fong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20100956     DOI： 10.1200/JCO.2009.26.3483

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic cancer vaccines: are we there yet?

Authors:  Christopher A Klebanoff; Nicolas Acquavella; Zhiya Yu; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.

Authors:  Lilin Lai; Suefen Kwa; Pamela A Kozlowski; David C Montefiori; Guido Ferrari; Welkin E Johnson; Vanessa Hirsch; Francois Villinger; Lakshmi Chennareddi; Patricia L Earl; Bernard Moss; Rama Rao Amara; Harriet L Robinson
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 3.  Improved endpoints for cancer immunotherapy trials.

Authors:  Axel Hoos; Alexander M M Eggermont; Sylvia Janetzki; F Stephen Hodi; Ramy Ibrahim; Aparna Anderson; Rachel Humphrey; Brent Blumenstein; Lloyd Old; Jedd Wolchok
Journal:  J Natl Cancer Inst       Date:  2010-09-08       Impact factor: 13.506

4.  Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

Authors:  Marie L Huber; Laura Haynes; Chris Parker; Peter Iversen
Journal:  J Natl Cancer Inst       Date:  2012-01-09       Impact factor: 13.506

Review 5.  The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014.

Authors:  Paolo A Ascierto; Raffaele Addeo; Giacomo Cartenì; Bruno Daniele; Michele De Laurentis; Giovanni Pietro Ianniello; Alessandro Morabito; Giovannella Palmieri; Stefano Pepe; Francesco Perrone; Sandro Pignata; Vincenzo Montesarchio
Journal:  J Transl Med       Date:  2014-10-21       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.